CN103041239A - Medicine composition - Google Patents
Medicine composition Download PDFInfo
- Publication number
- CN103041239A CN103041239A CN2012105470485A CN201210547048A CN103041239A CN 103041239 A CN103041239 A CN 103041239A CN 2012105470485 A CN2012105470485 A CN 2012105470485A CN 201210547048 A CN201210547048 A CN 201210547048A CN 103041239 A CN103041239 A CN 103041239A
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- herba
- medicine composition
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composition. The medicine composition comprises the following components in terms of weight: 10-15 g musk ketone, 10-15 g albiflorin, 20-25 g frankincense, 5-10 g myrrh, 2-5 g hedyotis diffusa, 4-7 g lycopodium clavatum, 7-14 g saussurea involucrata, 1-3 g cinnamon, 8-15 g herba violae , 7-19 g rhizoma smilacis glabrae, 16-23 g south minium, 2-4 g fresh locust, 7-13 g garden balsam stem, 11-15 g radix paeoniae rubra, 14-19 g rhizoma atractylodis, 20-25 g cortex lycii radicis, 13-16 g crocus sativus, 10-17 g golden cypress, 3-8 g groundsel and 1-5 g divaricate saposhnikovia root. The medicine composition provided by the invention has the advantages of easiness in processing, convenience in use, quick curative effect, no toxic and side effect and the like.
Description
Technical field
The present invention relates to pharmaceutical composition.
Background technology
Moschus is the representative medicine commonly used of aromatic and inducing resuscitation Chinese medicine, and Moschus has stronger central nervous system's excitement and suppresses the pharmacologically actives such as amphicheirality's effect, resisting oxygen lack, cardiac vascular activity, antiinflammatory action.At present, Moschus application (especially cardiovascular and cerebrovascular disease) clinically is very extensive, and for example compound Salviae Miltiorrhizae class, storax pill for treating coronary heart disease, cow-bezoar bolus for resurrection, HUATUO ZAIZAO WAN, refreshment wait all containing Moschus quietly.At this quasi-tradition Cheng Fangzhong, utilized the effect of Moschus " fragrance is walked to alter, inducing resuscitation (seeing through blood brain barrier) " more, produce " returning through entering brain " effect (Shandong medical industry 2002,21 (1): 26-27; Hour hands traditional Chinese medical science traditional Chinese medicines 2004,15 (4) 4248-249; New Chinese medicine and clinical pharmacology 2000,11 (4): 208-255).
For many years, many scholars have done extensive work based on modern medical theory to the aspects such as pharmacodynamics, pharmacokinetics and safety of Moschus, have obtained many new developments.For example, research is found: Moschus is returned the experimental study (Chen Wen high and dry land etc., Journal of Chinese Integrative Medicine the 4th phase of the 2nd volume July in 2004) through entering brain; With Moschus Borneolum Syntheticum combination cerebral protection (Shen Qiang etc., Moschus and Borneolum Syntheticum on the impact of global cerebral ischemic-reperfusion rat cerebral tissue interleukin-1 ' beta ' mrna expression, time treasure's traditional Chinese medical science traditional Chinese medicines the 7th phase of the 14th volume in 2003).
Yet above-mentioned compound recipe can not satisfy demand clinically far away.On the one hand, existing compound recipe normally forms by the principle of " determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs ", and this is complicated for pathogenesis, with the disease of different classes of complication, and these Moschus compound preparations are difficult to multi-faceted proving effective.More crucial is, these large compound medicine compositions are too complicated, and the interaction between each composition is not clear, does not meet the trend of modern medicines, the homogeneity that is difficult to ensure the quality of products.
Summary of the invention
The inventor has carried out the experimental study of Radix Paeoniae, Moschus and the combination of other vasoactive agents, found that compositions possesses better effect equally.
The present invention relates to a kind of pharmaceutical composition, component by following weight portion forms, muscone 10-15 gram, lactone glucoside of Radix Paeoniae 10-15 gram, Olibanum 20-25 gram, Myrrha 5-10 gram, Herba Hedyotidis Diffusae 2-5 gram, Herba Lycopodii 4-7 gram, Herba Saussureae Involueratae 7-14 gram, Cortex Cinnamomi 1-3 gram, Herba Violae 8-15 gram, Rhizoma Smilacis Glabrae 7-19 gram, southern Plumbum preparatium 16-23 gram, bright Sophora japonica L. 2-4 gram, Herba speranskiae tuberculatae 7-13 gram, Radix Polygoni Ciliinerve 11-15 gram, Rhizoma Atractylodis Macrocephalae 14-19 gram, Cortex Lycii 20-25 gram, Stigma Croci 13-16 gram, Cortex Phellodendri 10-17 gram, Herba Senecionis Scandentis 3-8 gram, Radix Saposhnikoviae 1-5 gram.
Get above-mentioned raw materials and add in 2000 ml waters, soaked 1-2 hour, slow fire 20-40 minute, obtain medicinal liquid, granulate and the tablet forming technique preparation according to standard.
The specific embodiment
Embodiment 1
The present invention relates to a kind of pharmaceutical composition, component by following weight portion forms, muscone 10 grams, lactone glucoside of Radix Paeoniae 10 grams, Olibanum 20 grams, Myrrha 5 grams, Herba Hedyotidis Diffusae 2 grams, Herba Lycopodii 4 grams, Herba Saussureae Involueratae 7 grams, Cortex Cinnamomi 1 gram, Herba Violae 8 grams, Rhizoma Smilacis Glabrae 7 grams, southern Plumbum preparatium 16 grams, bright Sophora japonica L. 2 grams, Herba speranskiae tuberculatae 7 grams, Radix Polygoni Ciliinerve 11 grams, the Rhizoma Atractylodis Macrocephalae 14 grams, Cortex Lycii 20 grams, Stigma Croci 13 grams, Cortex Phellodendri 10 grams, Herba Senecionis Scandentis 3 grams, Radix Saposhnikoviae 1 gram.
Embodiment 2
The present invention relates to a kind of pharmaceutical composition, component by following weight portion forms, muscone 15 grams, lactone glucoside of Radix Paeoniae 15 grams, Olibanum 25 grams, Myrrha 10 grams, Herba Hedyotidis Diffusae 5 grams, Herba Lycopodii 7 grams, Herba Saussureae Involueratae 14 grams, Cortex Cinnamomi 3 grams, Herba Violae 15 grams, Rhizoma Smilacis Glabrae 19 grams, southern Plumbum preparatium 23 grams, bright Sophora japonica L. 4 grams, Herba speranskiae tuberculatae 13 grams, Radix Polygoni Ciliinerve 15 grams, the Rhizoma Atractylodis Macrocephalae 19 grams, Cortex Lycii 25 grams, Stigma Croci 16 grams, Cortex Phellodendri 17 grams, Herba Senecionis Scandentis 8 grams, Radix Saposhnikoviae 5 grams.
Embodiment 3
The present invention relates to a kind of pharmaceutical composition, component by following weight portion forms, muscone 13 grams, lactone glucoside of Radix Paeoniae 12 grams, Olibanum 21 grams, Myrrha 7 grams, Herba Hedyotidis Diffusae 4 grams, Herba Lycopodii 6 grams, Herba Saussureae Involueratae 9 grams, Cortex Cinnamomi 2 grams, Herba Violae 9 grams, Rhizoma Smilacis Glabrae 8 grams, southern Plumbum preparatium 19 grams, bright Sophora japonica L. 3 grams, Herba speranskiae tuberculatae 8 grams, Radix Polygoni Ciliinerve 14 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Cortex Lycii 21 grams, Stigma Croci 14 grams, Cortex Phellodendri 16 grams, Herba Senecionis Scandentis 7 grams, Radix Saposhnikoviae 3 grams.
Claims (1)
1. pharmaceutical composition, it is characterized in that: the component by following weight portion forms, muscone 10-15 gram, lactone glucoside of Radix Paeoniae 10-15 gram, Olibanum 20-25 gram, Myrrha 5-10 gram, Herba Hedyotidis Diffusae 2-5 gram, Herba Lycopodii 4-7 gram, Herba Saussureae Involueratae 7-14 gram, Cortex Cinnamomi 1-3 gram, Herba Violae 8-15 gram, Rhizoma Smilacis Glabrae 7-19 gram, southern Plumbum preparatium 16-23 gram, bright Sophora japonica L. 2-4 gram, Herba speranskiae tuberculatae 7-13 gram, Radix Polygoni Ciliinerve 11-15 gram, Rhizoma Atractylodis Macrocephalae 14-19 gram, Cortex Lycii 20-25 gram, Stigma Croci 13-16 gram, Cortex Phellodendri 10-17 gram, Herba Senecionis Scandentis 3-8 gram, Radix Saposhnikoviae 1-5 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105470485A CN103041239A (en) | 2012-12-17 | 2012-12-17 | Medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105470485A CN103041239A (en) | 2012-12-17 | 2012-12-17 | Medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103041239A true CN103041239A (en) | 2013-04-17 |
Family
ID=48054250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105470485A Pending CN103041239A (en) | 2012-12-17 | 2012-12-17 | Medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041239A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138437A (en) * | 2014-08-14 | 2014-11-12 | 范恒银 | Traditional Chinese medicine preparation for treating arrhythmia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1337241A (en) * | 2000-08-07 | 2002-02-27 | 盖玉宝 | Pus drawing out and blood circulation promoting ointment |
| CN1846770A (en) * | 2006-02-20 | 2006-10-18 | 毕敬东 | Ointment for treating rheumatism, wound pain and swelling boil |
-
2012
- 2012-12-17 CN CN2012105470485A patent/CN103041239A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1337241A (en) * | 2000-08-07 | 2002-02-27 | 盖玉宝 | Pus drawing out and blood circulation promoting ointment |
| CN1846770A (en) * | 2006-02-20 | 2006-10-18 | 毕敬东 | Ointment for treating rheumatism, wound pain and swelling boil |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138437A (en) * | 2014-08-14 | 2014-11-12 | 范恒银 | Traditional Chinese medicine preparation for treating arrhythmia |
| CN104138437B (en) * | 2014-08-14 | 2016-05-18 | 朱玉芳 | One is treated ARR Chinese medicine preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bu et al. | Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis | |
| CN101357136B (en) | Composition of traditional Chinese medicine effective constituent for preventing and treating diseased associated with cerebral ischemia injury | |
| Gu et al. | The PI3K/AKT pathway—The potential key mechanisms of traditional Chinese medicine for stroke | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| Zhang et al. | Mechanisms and status of research on the protective effects of traditional Chinese medicine against ischemic brain injury | |
| CN109276591B (en) | New application of acanthopanax, angelica and astragalus composition in assisting in reducing blood sugar | |
| CN104288245A (en) | Pharmaceutical composition having functions of defying age and enhancing physique, preparation method and detection method thereof | |
| CN103041239A (en) | Medicine composition | |
| CN102357226A (en) | Application of Chinese herbal medicine turmeric extraction in preparation of slimming and lipid-lowering drug or drug with lipase activity inhibition effect | |
| CN102357142A (en) | Use of water extract or ethanol extract of Chinese herbal medicine seville orange flower in preparation of drug for losing weight and reducing blood fat or drug for inhibiting lipase activity | |
| CN102366428A (en) | Applications of extracts from Chinese herbal medicine Oroxylum indicum in preparation of slimming and lipid lowering medicine or preparation of medicine with inhibition effect on activity of lipase | |
| CN1242778C (en) | Hemiplegia treating pill | |
| CN102366433A (en) | Application of Chinese medicinal chrysanthemum extract in preparing weight-losing and lipid-lowering medicaments or lipase activity-inhibiting medicaments | |
| CN102114211B (en) | Chinese herbal medicine for treating hepatitis | |
| KR20220121247A (en) | Compound preparation for nerve regeneration and method and use thereof | |
| CN101371877B (en) | Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same | |
| Liu et al. | Medicinal Plants for Cardiovascular and Neurodegenerative Aging-Related Diseases: From Bench to Bedside | |
| CN102258699A (en) | Chinese patent medicament for treating cervical spondylosis and cranial nerve vascular diseases and preparation method thereof | |
| CN108126154A (en) | A kind of preparation method and application for the nano dispersion fluid for treating obstruction of collaterals by blood stasis arthralgia-syndrome pain | |
| CN1488382A (en) | Health-care medicine for preventing and curing cardio-cerebrovascular diseae | |
| Sodovjamts et al. | The Effect of Antischemin Preparations on Hypoxia | |
| Wang et al. | Compatibility mechanism of Chinese medicine formula: state of the art and perspectives | |
| CN102397304A (en) | Application of Chinese herbal medicine ginkgo biloba extract to preparation of medicament for reducing weight and lipid or preparation of medicament with lipase activity inhibitory action | |
| CN102370694A (en) | Application of Chinese herbal medicine shrubby sophora extract to preparation of weight losing and lipid lowering medicament or medicament with lipase activity suppression effect | |
| CN102366429A (en) | Application of extract of Chinese herbal medicine notopterygium root in preparing medicines for reducing weight and fat or medicines having effect of inhibiting lipase activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130417 |